chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: pain expanded to the fingers of his left arm; "horrible pain" in arm; "horrible pain" going to the jaw; experienced chills; body aches; fever at night time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW ("horrible pain" going to the jaw), CHILLS (experienced chills), MYALGIA (body aches), PYREXIA (fever at night time) and VACCINATION SITE PAIN ("horrible pain" in arm) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032N20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced CHILLS (experienced chills), MYALGIA (body aches) and PYREXIA (fever at night time). On 10-Mar-2021, the patient experienced PAIN IN JAW ("horrible pain" going to the jaw) and VACCINATION SITE PAIN ("horrible pain" in arm). On 11-Mar-2021, the patient experienced ARTHRALGIA (pain expanded to the fingers of his left arm). At the time of the report, PAIN IN JAW ("horrible pain" going to the jaw), CHILLS (experienced chills), MYALGIA (body aches), PYREXIA (fever at night time), VACCINATION SITE PAIN ("horrible pain" in arm) and ARTHRALGIA (pain expanded to the fingers of his left arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Blood pressure measurement: 166/112 (High) blood pressure increased.         Concomitant product use was not provided by the reporter.   ? No treatment information was provided. ? The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. ? Action taken with mRNA-1273 in response to the event was not applicable.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Husband started with nose bleed 20 minutes after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Husband started with nose bleed 20 minutes after receiving 1st dose) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient's medical history included No Adverse event.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced EPISTAXIS (Husband started with nose bleed 20 minutes after receiving 1st dose). At the time of the report, EPISTAXIS (Husband started with nose bleed 20 minutes after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included Blood thinner  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative
Clinical narrative: several antibody tests and they come back negative even though she has had both shots of the Covid vaccin; This spontaneous case was reported by an other health care professional and describes the occurrence of ANTIBODY TEST NEGATIVE (several antibody tests and they come back negative even though she has had both shots of the Covid vaccin) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (several antibody tests and they come back negative even though she has had both shots of the Covid vaccin). At the time of the report, ANTIBODY TEST NEGATIVE (several antibody tests and they come back negative even though she has had both shots of the Covid vaccin) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Injection site a red round (like circle) is worm in touch and itchy; Injection site a red round (like circle) is worm in touch and itchy; Injection site a red round (like circle) is worm in touch and itchy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site a red round (like circle) is worm in touch and itchy), VACCINATION SITE PRURITUS (Injection site a red round (like circle) is worm in touch and itchy) and VACCINATION SITE ERYTHEMA (Injection site a red round (like circle) is worm in touch and itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site a red round (like circle) is worm in touch and itchy), VACCINATION SITE PRURITUS (Injection site a red round (like circle) is worm in touch and itchy) and VACCINATION SITE ERYTHEMA (Injection site a red round (like circle) is worm in touch and itchy). The patient was treated with CORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site a red round (like circle) is worm in touch and itchy), VACCINATION SITE PRURITUS (Injection site a red round (like circle) is worm in touch and itchy) and VACCINATION SITE ERYTHEMA (Injection site a red round (like circle) is worm in touch and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Non significant follow up received on 21-MAY-2021, no new information
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: improperly stored vaccine administered; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (improperly stored vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PRODUCT STORAGE ERROR (improperly stored vaccine administered). On 28-Jan-2021, PRODUCT STORAGE ERROR (improperly stored vaccine administered) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Vaccination site erythema, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: His arm felt a little hot and stiffer than the left arm; Right arm felt stiffer than left arm; Swollen right arm; Red right arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (His arm felt a little hot and stiffer than the left arm), VACCINATION SITE INDURATION (Right arm felt stiffer than left arm), VACCINATION SITE SWELLING (Swollen right arm) and VACCINATION SITE ERYTHEMA (Red right arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included VITAMINS NOS, ATORVASTATIN CALCIUM (LIPITOR), VALSARTAN and OMEPRAZOLE for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (His arm felt a little hot and stiffer than the left arm), VACCINATION SITE INDURATION (Right arm felt stiffer than left arm), VACCINATION SITE SWELLING (Swollen right arm) and VACCINATION SITE ERYTHEMA (Red right arm). At the time of the report, VACCINATION SITE WARMTH (His arm felt a little hot and stiffer than the left arm), VACCINATION SITE INDURATION (Right arm felt stiffer than left arm), VACCINATION SITE SWELLING (Swollen right arm) and VACCINATION SITE ERYTHEMA (Red right arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site cellulitis, Vaccination site erythema, Vaccination site induration, Vaccination site infection, Vaccination site pain
Clinical narrative: Cellulitis Injection Site; Infected Injection Site; Hard to the touch Injection Site; Itching Injection Site; Rash Injection Site; Red Injection Site; Swollen Injection Site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE RASH (Rash Injection Site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 01-Mar-2021, the patient experienced VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Rash Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site). The patient was treated with CLINDAMYCIN at a dose of 300 milligram once a day. On 23-Feb-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Rash Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Event outcome updated
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Cellulitis Injection Site; Infected Injection Site; Hard to the touch Injection Site; Itching Injection Site; Rash Injection Site; Red Injection Site; Swollen Injection Site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site) and VACCINATION SITE RASH (Rash Injection Site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 01-Mar-2021, the patient experienced VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Rash Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site). The patient was treated with CLINDAMYCIN at a dose of 300 milligram once a day. On 23-Feb-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (Cellulitis Injection Site), VACCINATION SITE INFECTION (Infected Injection Site), VACCINATION SITE INDURATION (Hard to the touch Injection Site), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Rash Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and VACCINATION SITE SWELLING (Swollen Injection Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Event outcome updated
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Induration, Pruritus, Swelling
Clinical narrative: Severe itching on toes; Severe itching on feet; Toes are swollen; Toes are still blistering; Toes are red; spot on the left side of back near kidney; (spot) hard; (spot) swollen; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Toes are still blistering), INDURATION ((spot) hard), PRURITUS (Severe itching on toes), PRURITUS (Severe itching on feet) and SWELLING (Toes are swollen) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE, PROPRANOLOL, MAGNESIUM and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced INDURATION ((spot) hard), SWELLING ((spot) swollen) and SWELLING (spot on the left side of back near kidney). On 02-Mar-2021, the patient experienced BLISTER (Toes are still blistering), PRURITUS (Severe itching on toes), PRURITUS (Severe itching on feet), SWELLING (Toes are swollen) and ERYTHEMA (Toes are red). At the time of the report, BLISTER (Toes are still blistering), INDURATION ((spot) hard), PRURITUS (Severe itching on toes), PRURITUS (Severe itching on feet), SWELLING (Toes are swollen), SWELLING ((spot) swollen), ERYTHEMA (Toes are red) and SWELLING (spot on the left side of back near kidney) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was not reported
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Diarrhoea, Fatigue, Pyrexia
Clinical narrative: Severe diarrhea for 3 hours which came almost like water; Feeling very weak; Could not step out of the bed; Temperature ranging from 102-103; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea for 3 hours which came almost like water), ASTHENIA (Feeling very weak), FATIGUE (Could not step out of the bed) and PYREXIA (Temperature ranging from 102-103) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced DIARRHOEA (Severe diarrhea for 3 hours which came almost like water), ASTHENIA (Feeling very weak), FATIGUE (Could not step out of the bed) and PYREXIA (Temperature ranging from 102-103). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 10-Mar-2021, DIARRHOEA (Severe diarrhea for 3 hours which came almost like water), ASTHENIA (Feeling very weak), FATIGUE (Could not step out of the bed) and PYREXIA (Temperature ranging from 102-103) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 102 (High) Temperature of 102. On 09-Mar-2021, Body temperature: 103 (High) Temperature raised to 103.         No concomitant medications were provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Contusion, Diarrhoea, Dizziness, Erythema
Clinical narrative: Acute allergies; Little dizzy; Feels like a bruise; Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it; Red; Fatigue; Back ache; Headache; Nausea; Sore arm; Woke up drenched; Vertigo; Diarrhea; Achy; Got very itchy; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), PRURITUS (Got very itchy), DIARRHOEA (Diarrhea) and PAIN (Achy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (Got very itchy). On 27-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN (Achy), PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Woke up drenched), VERTIGO (Vertigo), BACK PAIN (Back ache), HEADACHE (Headache) and NAUSEA (Nausea). On an unknown date, the patient experienced HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), CONTUSION (Feels like a bruise), VACCINATION SITE REACTION (Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it), ERYTHEMA (Red) and FATIGUE (Fatigue). At the time of the report, HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), PRURITUS (Got very itchy), DIARRHOEA (Diarrhea), PAIN (Achy), CONTUSION (Feels like a bruise), PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Woke up drenched), VERTIGO (Vertigo), VACCINATION SITE REACTION (Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it), ERYTHEMA (Red), BACK PAIN (Back ache), HEADACHE (Headache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Hypersensitivity, Nausea
Clinical narrative: Acute allergies; Little dizzy; Feels like a bruise; Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it; Red; Fatigue; Back ache; Headache; Nausea; Sore arm; Woke up drenched; Vertigo; Diarrhea; Achy; Got very itchy; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), PRURITUS (Got very itchy), DIARRHOEA (Diarrhea) and PAIN (Achy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (Got very itchy). On 27-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN (Achy), PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Woke up drenched), VERTIGO (Vertigo), BACK PAIN (Back ache), HEADACHE (Headache) and NAUSEA (Nausea). On an unknown date, the patient experienced HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), CONTUSION (Feels like a bruise), VACCINATION SITE REACTION (Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it), ERYTHEMA (Red) and FATIGUE (Fatigue). At the time of the report, HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), PRURITUS (Got very itchy), DIARRHOEA (Diarrhea), PAIN (Achy), CONTUSION (Feels like a bruise), PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Woke up drenched), VERTIGO (Vertigo), VACCINATION SITE REACTION (Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it), ERYTHEMA (Red), BACK PAIN (Back ache), HEADACHE (Headache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pruritus, Vaccination site reaction, Vertigo
Clinical narrative: Acute allergies; Little dizzy; Feels like a bruise; Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it; Red; Fatigue; Back ache; Headache; Nausea; Sore arm; Woke up drenched; Vertigo; Diarrhea; Achy; Got very itchy; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), PRURITUS (Got very itchy), DIARRHOEA (Diarrhea) and PAIN (Achy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (Got very itchy). On 27-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN (Achy), PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Woke up drenched), VERTIGO (Vertigo), BACK PAIN (Back ache), HEADACHE (Headache) and NAUSEA (Nausea). On an unknown date, the patient experienced HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), CONTUSION (Feels like a bruise), VACCINATION SITE REACTION (Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it), ERYTHEMA (Red) and FATIGUE (Fatigue). At the time of the report, HYPERSENSITIVITY (Acute allergies), DIZZINESS (Little dizzy), PRURITUS (Got very itchy), DIARRHOEA (Diarrhea), PAIN (Achy), CONTUSION (Feels like a bruise), PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Woke up drenched), VERTIGO (Vertigo), VACCINATION SITE REACTION (Delayed reactions sore arm, red, swollen, itchy, feels like a bruise, and hurts to touch it), ERYTHEMA (Red), BACK PAIN (Back ache), HEADACHE (Headache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Urinary tract infection, Urine analysis
Clinical narrative: positive UTI test; excruciating back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (excruciating back pain) and URINARY TRACT INFECTION (positive UTI test) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced BACK PAIN (excruciating back pain). On 12-Mar-2021, the patient experienced URINARY TRACT INFECTION (positive UTI test). At the time of the report, BACK PAIN (excruciating back pain) and URINARY TRACT INFECTION (positive UTI test) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Urine analysis: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information were provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain
Clinical narrative: experienced trouble in walking for 2 days and she is still limping; Limping; Feels pain sometimes; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (experienced trouble in walking for 2 days and she is still limping), GAIT DISTURBANCE (Limping) and PAIN (Feels pain sometimes) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced GAIT DISTURBANCE (experienced trouble in walking for 2 days and she is still limping), GAIT DISTURBANCE (Limping) and PAIN (Feels pain sometimes). At the time of the report, GAIT DISTURBANCE (experienced trouble in walking for 2 days and she is still limping) had not resolved and GAIT DISTURBANCE (Limping) and PAIN (Feels pain sometimes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       In concomitant medications thyroid medicines was reported. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling; Arm at injection site is still painful,Sore, Painful to lay down on the side; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Arm at injection site is still painful,Sore, Painful to lay down on the side) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Arm at injection site is still painful,Sore, Painful to lay down on the side). At the time of the report, VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Arm at injection site is still painful,Sore, Painful to lay down on the side) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported Treatment medications were not reoprted
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: Lays down or woke up in the morning gets really dizzy and takes several hours for the head to Come down; Stuffy; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Lays down or woke up in the morning gets really dizzy and takes several hours for the head to Come down) and DYSPNOEA (Stuffy) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced DIZZINESS (Lays down or woke up in the morning gets really dizzy and takes several hours for the head to Come down) and DYSPNOEA (Stuffy). At the time of the report, DIZZINESS (Lays down or woke up in the morning gets really dizzy and takes several hours for the head to Come down) and DYSPNOEA (Stuffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 09-Mar-2021 for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, Fatigue, Musculoskeletal stiffness, X-ray
Clinical narrative: Pain in abdomen area has spread some to back; Tired; Stiffness; Pain in abdomen area; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness), ABDOMINAL PAIN (Pain in abdomen area), BACK PAIN (Pain in abdomen area has spread some to back) and FATIGUE (Tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness), ABDOMINAL PAIN (Pain in abdomen area) and FATIGUE (Tired). On 01-Mar-2021, the patient experienced BACK PAIN (Pain in abdomen area has spread some to back). On 18-Feb-2021, FATIGUE (Tired) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness), ABDOMINAL PAIN (Pain in abdomen area) and BACK PAIN (Pain in abdomen area has spread some to back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jun-2021, X-ray: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up received on 22 Jun 2021. Contact information updated. Lab information updated.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain is still felt on the right arm from the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain is still felt on the right arm from the first dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain is still felt on the right arm from the first dose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (pain is still felt on the right arm from the first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Additional concomitant medication includes allergy pills which the patient takes everyday. No further information was provided.   This case was linked to MOD-2021-043052 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Sore arm; headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (Tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (Tired). At the time of the report, PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (Tired) had resolved.            Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: left arm hot; left arm hardness; left arm itchy; left arm swollen a little bit; 3 little red marks on left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (left arm hot), VACCINATION SITE INDURATION (left arm hardness), VACCINATION SITE PRURITUS (left arm itchy), VACCINATION SITE SWELLING (left arm swollen a little bit) and VACCINATION SITE ERYTHEMA (3 little red marks on left arm) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, AMLODIPINE and RIVAROXABAN (XARELTO) for an unknown indication.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE WARMTH (left arm hot), VACCINATION SITE INDURATION (left arm hardness), VACCINATION SITE PRURITUS (left arm itchy), VACCINATION SITE SWELLING (left arm swollen a little bit) and VACCINATION SITE ERYTHEMA (3 little red marks on left arm). At the time of the report, VACCINATION SITE WARMTH (left arm hot), VACCINATION SITE INDURATION (left arm hardness), VACCINATION SITE PRURITUS (left arm itchy), VACCINATION SITE SWELLING (left arm swollen a little bit) and VACCINATION SITE ERYTHEMA (3 little red marks on left arm) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient treated symptoms with ice.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: More than the 42 days window patient got his first shot of vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than the 42 days window patient got his first shot of vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than the 42 days window patient got his first shot of vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than the 42 days window patient got his first shot of vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Achy; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achy) and CHILLS (chills) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (Achy) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 14-Feb-2021, MYALGIA (Achy) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient was doing fine after receiving both shots of the vaccine. Concomitant medications were not provided.    This case was linked to MOD-2021-058087 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Event details updated
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Musculoskeletal stiffness, Paraesthesia
Clinical narrative: Numbness; Tingling feeling down on her lower left leg going up to face to her eyebrow; Left side of her body was stiff; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling feeling down on her lower left leg going up to face to her eyebrow) and MUSCULOSKELETAL STIFFNESS (Left side of her body was stiff) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02UM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness) and PARAESTHESIA (Tingling feeling down on her lower left leg going up to face to her eyebrow). 28-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Left side of her body was stiff). On 03-Mar-2021, HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling feeling down on her lower left leg going up to face to her eyebrow) and MUSCULOSKELETAL STIFFNESS (Left side of her body was stiff) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Rash on the left shoulder; pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the left arm) and RASH (Rash on the left shoulder) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Pain in extremity on 11-Mar-2021, Rash on 12-Mar-2021 and Drug allergy.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in the left arm). On 12-Mar-2021, the patient experienced RASH (Rash on the left shoulder). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (pain in the left arm) and RASH (Rash on the left shoulder) outcome was unknown.            Concomitant medications were not reported.   This case was linked to MOD-2021-043046 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Muscle spasm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasm) in a female patient of an unknown age who received mRNA-1273 for COVID-19 vaccination.     Concurrent medical conditions included Muscle pain.    On an unknown date, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Muscle spasm). At the time of the report, MUSCLE SPASMS (Muscle spasm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   Reporter did not allow further contact
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance
Clinical narrative: Overall weakness; She could barely walk to her chair; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Overall weakness) and GAIT DISTURBANCE (She could barely walk to her chair) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder and Blood pressure. Concomitant products included OLMESARTAN for Blood pressure, LEVOTHYROXINE for Thyroid disorder.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced ASTHENIA (Overall weakness) and GAIT DISTURBANCE (She could barely walk to her chair). At the time of the report, ASTHENIA (Overall weakness) and GAIT DISTURBANCE (She could barely walk to her chair) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient experienced overall weakness after taking Levothyroxine, the medication she takes for her thyroid. The day she received the vaccine, she took her blood pressure medication (Olmesartan) much later than she normally takes which she usually takes in the morning. She took one tablet of  8 hours arthritis pain relief. She stated that had been fine since that day.
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Dizziness, Feeling abnormal, Feeling cold, Feeling hot
Clinical narrative: Really weird; Weak back of legs; Dizziness/ light headed like a fog; Hard to concentrate; Arm pain at injection site; Hot & cold flashes; Hot & cold flashes; Had exactly 40 hours of feeling warm; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot & cold flashes), FEELING COLD (Hot & cold flashes), FEELING HOT (Had exactly 40 hours of feeling warm), FEELING ABNORMAL (Really weird) and MUSCULAR WEAKNESS (Weak back of legs) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atrial fibrillation, Blood pressure high, High cholesterol, Sugar blood decreased (Low sugar level at times, but does not have a glucometer to access) and Blood pressure high.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced HOT FLUSH (Hot & cold flashes), FEELING COLD (Hot & cold flashes), FEELING HOT (Had exactly 40 hours of feeling warm) and VACCINATION SITE PAIN (Arm pain at injection site). On 12-Mar-2021, the patient experienced FEELING ABNORMAL (Really weird), MUSCULAR WEAKNESS (Weak back of legs), DIZZINESS (Dizziness/ light headed like a fog) and DISTURBANCE IN ATTENTION (Hard to concentrate). On 10-Mar-2021, HOT FLUSH (Hot & cold flashes), FEELING COLD (Hot & cold flashes), FEELING HOT (Had exactly 40 hours of feeling warm) and VACCINATION SITE PAIN (Arm pain at injection site) had resolved. At the time of the report, FEELING ABNORMAL (Really weird), MUSCULAR WEAKNESS (Weak back of legs), DIZZINESS (Dizziness/ light headed like a fog) and DISTURBANCE IN ATTENTION (Hard to concentrate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was given. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Hot flush, Muscular weakness, Vaccination site pain
Clinical narrative: Really weird; Weak back of legs; Dizziness/ light headed like a fog; Hard to concentrate; Arm pain at injection site; Hot & cold flashes; Hot & cold flashes; Had exactly 40 hours of feeling warm; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot & cold flashes), FEELING COLD (Hot & cold flashes), FEELING HOT (Had exactly 40 hours of feeling warm), FEELING ABNORMAL (Really weird) and MUSCULAR WEAKNESS (Weak back of legs) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atrial fibrillation, Blood pressure high, High cholesterol, Sugar blood decreased (Low sugar level at times, but does not have a glucometer to access) and Blood pressure high.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced HOT FLUSH (Hot & cold flashes), FEELING COLD (Hot & cold flashes), FEELING HOT (Had exactly 40 hours of feeling warm) and VACCINATION SITE PAIN (Arm pain at injection site). On 12-Mar-2021, the patient experienced FEELING ABNORMAL (Really weird), MUSCULAR WEAKNESS (Weak back of legs), DIZZINESS (Dizziness/ light headed like a fog) and DISTURBANCE IN ATTENTION (Hard to concentrate). On 10-Mar-2021, HOT FLUSH (Hot & cold flashes), FEELING COLD (Hot & cold flashes), FEELING HOT (Had exactly 40 hours of feeling warm) and VACCINATION SITE PAIN (Arm pain at injection site) had resolved. At the time of the report, FEELING ABNORMAL (Really weird), MUSCULAR WEAKNESS (Weak back of legs), DIZZINESS (Dizziness/ light headed like a fog) and DISTURBANCE IN ATTENTION (Hard to concentrate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was given. No treatment information was provided.